Trial NCT00851552

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000635486
Secondary IDs: RPCI-I-136508

Last trial update was posted on 2014-07-21

MeSH Interventions

Bortezomib Doxorubicin Liposomal doxorubicin Rituximab

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse

Other Conditions


Stopping Reasons

Lack of sponsor support

Limitations And Caveats

Due to the study's early termination and inadequate number of patients, no patients were analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID